Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001083741 | SCV000261564 | benign | Gastrointestinal stromal tumor | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001010251 | SCV001170419 | benign | Hereditary cancer-predisposing syndrome | 2019-01-30 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000034502 | SCV002038875 | likely benign | not provided | 2021-06-11 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001010251 | SCV002536380 | benign | Hereditary cancer-predisposing syndrome | 2020-12-01 | criteria provided, single submitter | curation | |
Biesecker Lab/Clinical Genomics Section, |
RCV000034502 | SCV000043279 | variant of unknown significance | not provided | 2012-07-13 | no assertion criteria provided | research | Converted during submission to Uncertain significance. |
Prevention |
RCV003904893 | SCV004727790 | benign | KIT-related disorder | 2019-12-24 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |